GGrantIndex
← Leaderboards

Zoe Arvanitakis

Rush University Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$13,794,895
Attributed
$23,426,887
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.9M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,426,887 · 9

By mechanism

RF1$9,568,974 · 3
R01$9,085,919 · 4
U24$3,995,531 · 1
K23$776,463 · 1

Top collaborators

Most similar at Rush University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposAutopsyPersonsCognitiveBrainImpaired CognitionS DiseasePathologicNeuropathologyCognitive FunctionAgingCommunitiesCessation Of LifeCognitionClinical DataCerebrovascular DisordersLinkPathway InteractionsDementiaCohort StudiesBrain TissuePathologyBlood VesselsFreezing

Grant awards (23)

ReCARDO: Using Real-World Data to Derive Common Data Elements for Alzheimer's Disease and AD-Related Dementias Research Through Ontological Innovation$3,995,531
U24 · FY2025 · AG
The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black persons$1,073,896
R01 · FY2025 · AG · contact PI
Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4$780,961
R01 · FY2025 · AG
The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black persons$1,085,446
R01 · FY2024 · AG · contact PI
Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4 Diversity Supplement$75,593
RF1 · FY2024 · AG
Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4$2,417,667
RF1 · FY2022 · AG
The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black persons$3,275,232
RF1 · FY2021 · AG · contact PI
Linking peripheral and brain insulin resistance to AD neuropathology and cognition$3,800,482
RF1 · FY2018 · AG · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$617,586
R01 · FY2018 · NS · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$621,171
R01 · FY2017 · NS · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$638,544
R01 · FY2016 · NS · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$649,507
R01 · FY2015 · NS · contact PI
Vascular Cognitive and Motor Decline: Impact of aPL$527,363
R01 · FY2015 · AG · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$670,619
R01 · FY2014 · NS · contact PI
Vascular Cognitive and Motor Decline: Impact of aPL$584,373
R01 · FY2014 · AG · contact PI
Vascular Cognitive and Motor Decline: Impact of aPL$572,939
R01 · FY2013 · AG · contact PI
Vascular Cognitive and Motor Decline: Impact of aPL$614,993
R01 · FY2012 · AG · contact PI
Vascular Cognitive and Motor Decline: Impact of aPL$648,521
R01 · FY2011 · AG · contact PI
Oxidative Stress, Aging and Alzheimer's Disease$155,478
K23 · FY2009 · AG · contact PI
Oxidative Stress, Aging and Alzheimer's Disease$154,913
K23 · FY2008 · AG · contact PI
Oxidative Stress, Aging and Alzheimer's Disease$155,157
K23 · FY2007 · AG · contact PI
Oxidative Stress, Aging and Alzheimer's Disease$155,332
K23 · FY2006 · AG · contact PI
Oxidative Stress, Aging and Alzheimer's Disease$155,583
K23 · FY2005 · AG